This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2008:610:43-53.

doi: 10.1007/978-0-387-73898-7_4.

Beyond VEGF: targeting tumor growth and angiogenesis via alternative mechanisms

James Christensen¹, Kenna Anderes

Affiliations

PMID: 18593014
DOI: 10.1007/978-0-387-73898-7_4

Review

Beyond VEGF: targeting tumor growth and angiogenesis via alternative mechanisms

James Christensen et al. Adv Exp Med Biol. 2008.

. 2008:610:43-53.

doi: 10.1007/978-0-387-73898-7_4.

Authors

James Christensen¹, Kenna Anderes

Affiliation

¹ Department of Cancer Biology, Pfizer Global Research and Development, La Jolla Laboratories, La Jolla, CA 92121, USA. james.christensen@pfizer.com

PMID: 18593014
DOI: 10.1007/978-0-387-73898-7_4

No abstract available

PubMed Disclaimer

Similar articles

The selective class III/V receptor tyrosine kinase inhibitor SU11657 inhibits tumor growth and angiogenesis in experimental neuroblastomas grown in mice.
Bäckman U, Christofferson R. Bäckman U, et al. Pediatr Res. 2005 May;57(5 Pt 1):690-5. doi: 10.1203/01.PDR.0000156508.68065.AA. Epub 2005 Feb 17. Pediatr Res. 2005. PMID: 15718357
Anticancer drug discovery and development.
Colotta F. Colotta F. Adv Exp Med Biol. 2008;610:19-42. doi: 10.1007/978-0-387-73898-7_3. Adv Exp Med Biol. 2008. PMID: 18593013 Review. No abstract available.
Dual inhibition of Met kinase and angiogenesis to overcome HGF-induced EGFR-TKI resistance in EGFR mutant lung cancer.
Takeuchi S, Wang W, Li Q, Yamada T, Kita K, Donev IS, Nakamura T, Matsumoto K, Shimizu E, Nishioka Y, Sone S, Nakagawa T, Uenaka T, Yano S. Takeuchi S, et al. Am J Pathol. 2012 Sep;181(3):1034-43. doi: 10.1016/j.ajpath.2012.05.023. Epub 2012 Jul 9. Am J Pathol. 2012. PMID: 22789825
From anti-angiogenesis to anti-lymphangiogenesis: emerging trends in cancer therapy.
Stacker SA, Achen MG. Stacker SA, et al. Lymphat Res Biol. 2008;6(3-4):165-72. doi: 10.1089/lrb.2008.1015. Lymphat Res Biol. 2008. PMID: 19093789 Review.
Isogambogenic acid inhibits tumour angiogenesis by suppressing Rho GTPases and vascular endothelial growth factor receptor 2 signalling pathway.
Fan Y, Peng A, He S, Shao X, Nie C, Chen L. Fan Y, et al. J Chemother. 2013 Oct;25(5):298-308. doi: 10.1179/1973947813Y.0000000079. J Chemother. 2013. PMID: 24070138

See all similar articles

Cited by

Moderate Elevation of Homocysteine Induces Endothelial Dysfunction through Adaptive UPR Activation and Metabolic Rewiring.
Chatterjee B, Fatima F, Seth S, Sinha Roy S. Chatterjee B, et al. Cells. 2024 Jan 24;13(3):214. doi: 10.3390/cells13030214. Cells. 2024. PMID: 38334606 Free PMC article.
Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice.
Maione F, Capano S, Regano D, Zentilin L, Giacca M, Casanovas O, Bussolino F, Serini G, Giraudo E. Maione F, et al. J Clin Invest. 2012 May;122(5):1832-48. doi: 10.1172/JCI58976. Epub 2012 Apr 9. J Clin Invest. 2012. PMID: 22484816 Free PMC article.
Inhibition of c-Met reduces lymphatic metastasis in RIP-Tag2 transgenic mice.
Sennino B, Ishiguro-Oonuma T, Schriver BJ, Christensen JG, McDonald DM. Sennino B, et al. Cancer Res. 2013 Jun 15;73(12):3692-703. doi: 10.1158/0008-5472.CAN-12-2160. Epub 2013 Apr 10. Cancer Res. 2013. PMID: 23576559 Free PMC article.
Analyzing the factors that influence occult metastasis in oral tongue cancer.
Shin JH, Yoon HJ, Kim SM, Lee JH, Myoung H. Shin JH, et al. J Korean Assoc Oral Maxillofac Surg. 2020 Apr 30;46(2):99-107. doi: 10.5125/jkaoms.2020.46.2.99. J Korean Assoc Oral Maxillofac Surg. 2020. PMID: 32364349 Free PMC article.
VEGF and c-Met blockade amplify angiogenesis inhibition in pancreatic islet cancer.
You WK, Sennino B, Williamson CW, Falcón B, Hashizume H, Yao LC, Aftab DT, McDonald DM. You WK, et al. Cancer Res. 2011 Jul 15;71(14):4758-68. doi: 10.1158/0008-5472.CAN-10-2527. Epub 2011 May 25. Cancer Res. 2011. PMID: 21613405 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Springer